USFDA Flags Misleading Claims on Compounded Semaglutide, Tirzepatide Products sheeba farhat22 Jun 2026 5:24 PM ISTBengaluru: The U.S. Food and Drug Administration issued 25 warning letters to telehealth companies for marketing false and misleading claims about...
Novo Nordisk Reports Cybersecurity Breach Affecting Clinical Trial Patient Data sheeba farhat12 Jun 2026 10:23 PM ISTNew Delhi: Novo Nordisk said on Thursday it has identified a ​security incident in which ​certain information, including patient data from some...
Novo Nordisk Seeks Ban on Unregistered Semaglutide Products in South Africa sheeba farhat11 Jun 2026 6:07 PM ISTPretoria: Danish drugmaker Novo Nordisk is heading to court in South Africa on Wednesday to try to halt the sale of unapproved copies of semaglutide,...
Roche Obesity Drug Enicepatide Delivers 22.7% Weight Loss in Mid-Stage Trial, Challenges Wegovy, Zepbound sheeba farhat6 Jun 2026 11:16 PM ISTBengaluru: Roche said on Friday that patients lost 22.7% of their ​body weight in a mid-stage ​trial of its dual-acting experimental obesity drug,...
Novo Nordisk Bets on AI to Cut Drug Launch Timelines by Two-Thirds, Bengaluru Hub Takes Lead Role sheeba farhat26 May 2026 5:51 PM ISTBengaluru: Novo Nordisk is aiming to slash the time it takes to bring new drugs to market by up to two-thirds using AI, a top executive said, as the...
Novo Nordisk Nears Europe Launch of Oral Wegovy After EMA Recommendation sheeba farhat23 May 2026 5:02 PM ISTLondon: The European Medicines Agency recommended approval of Novo Nordisk's pill Wegovy, the regulator said on Friday, clearing the way for it to...
Eli Lilly Halts India Obesity Campaign After CDSCO Flags Indirect Promotion of Mounjaro MD Bureau12 May 2026 9:07 PM ISTHyderabad: Eli Lilly paused its obesity awareness campaign in India after the nation's drugs regulator warned the company it could violate rules...
India's Drug Panel Recommends Wegovy for Metabolic Liver Disease Treatment Susmita Roy10 May 2026 11:45 AM ISTNew Delhi: In a significant development for the treatment of liver diseases linked to obesity and metabolic disorders, the Subject Expert Committee...
Torrent Emerges Early Leader in India's Generic Semaglutide Race with 38% Market Share: Report Susmita Roy9 May 2026 5:23 PM ISTNew Delhi: Ahmedabad-based drug maker Torrent Pharma has emerged as the early frontrunner in India's fast-expanding generic semaglutide market,...
Amazon Pharmacy to Stock Novo Nordisk's Ozempic Pill, Offer Same-Day Delivery Across US sheeba farhat8 May 2026 4:26 PM ISTNew Delhi: Amazon said ​on Thursday its pharmacy will stock Novo Nordisk's Ozempic pill to treat type 2 diabetes at its kiosks and offer same-day...
The GLP-1 paradox: Rice study finds weight loss drugs may carry unexpected stigma Dr. Kamal Kant Kohli6 May 2026 10:00 AM ISTGlucagonlike peptide-1 (GLP-1) medications have taken over the national conversation around weight loss. From celebrity headlines to everyday...
Novo Nordisk, Eli Lilly Penalised in France for Indirect Promotion of Obesity Drugs sheeba farhat5 May 2026 7:03 PM ISTParis: France's medicine safety agency ANSM said Monday it had imposed fines on pharmaceutical firms Novo Nordisk and Eli Lilly over their advertising...
